M&A Deal Summary

Kerry Acquires c-LEcta

On February 15, 2022, Kerry acquired life science company c-LEcta from SHS Capital

Acquisition Highlights
  • This is Kerry’s 2nd transaction in the Life Science sector.
  • This is Kerry’s 2nd transaction in Germany.

M&A Deal Summary

Date 2022-02-15
Target c-LEcta
Sector Life Science
Buyer(s) Kerry
Sellers(s) SHS Capital
Deal Type Add-on Acquisition

Target

c-LEcta

Leipzig, Germany
c-LEcta is a developer of enzymes and microbial strains for industrial biotech applications in food, feed, pharma, and chemistry; a self-developed technology platform for the development of new enzymes. c-LEcta was founded in 2004 and is based in Leipzig, Germany.

Search 215,029 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Kerry

Tralee, Ireland

Category Company
Founded 1972
Sector Food
Employees21,461
Revenue 6.9B EUR (2024)
DESCRIPTION

Kerry together with its subsidiaries, develops, manufactures, and delivers technology based ingredients, flavors, and integrated solutions for the food, beverage, and pharmaceutical industries in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. Kerry was founded in 1972 and is based in Tralee, Ireland.


DEAL STATS #
Overall 19 of 19
Sector: Life Science M&A 2 of 2
Type: Add-on Acquisition M&A Deals 16 of 16
Country: Germany M&A 2 of 2
Year: 2022 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-06-21 Niacet

Niagara Falls, New York, United States

Niacet is a producer of specialty ingredients for food, feed, and pharmaceutical applications and the global leader in propionates and acetates. The Company’s propionates function as preservatives in baked goods and animal feed, while its acetates serve a wide variety of food and pharmaceutical applications. Niacet was established in 1978 and is based in Niagara Falls, New York.

Buy $1.0B

Seller(S) 1

SELLER
DESCRIPTION

SHS Capital is a private equity firm focused on the healthcare sector. Specific areas of interest include life science, medical technology, diagnostics, applied technologies, digital health, and industrial biotechnology. The Firm will consider opportunities at all company stages and looks to commit up to €50 million in businesses valued up to €150 million. Target geographies include Germany, Austria, Switzerland, Scandinavia, and Benelux. SHS Capital was established in 1993 and is headquartered in Tubingen, Germany.


DEAL STATS #
Overall 11 of 17
Sector: Life Science M&A 4 of 4
Type: Add-on Acquisition M&A Deals 6 of 10
Country: Germany M&A 8 of 13
Year: 2022 M&A 1 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-02-03 Lowenco

Vamdrup, Denmark

Lowenco is a manufacturer of large-scale ULT storage solutions for biotech and pharmaceutical companies. Lowenco was founded in 2013 and is headquartered in Vamdrup, Denmark.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-04-21 phenox

Bochum, Germany

phenox is a provider of neurovascular products. phenox's portfolio of products trans-catheter-based neurovascular interventions (treatment of ischemic as well as hemorrhagic stroke patients). The comprehensive product range (stent retriever, flow diverter, aspiration catheter, access, coil, balloon, etc.) is sold worldwide. phenox was founded in 2005 and is based in Bochum, Germany.

Sell €500M